A 73-year-old woman after percutaneous coronary intervention (PCI) of the left main (LM), left anterior descending (LAD) artery and diagonal branch with implantation of 5 drug-eluting stents (2020) was admitted due to heart failure exacerbation. Echocardiography showed left ventricular ejection fraction (LVEF) of 13%, severe secondary mitral regurgitation (MR) and moderate tricuspid regurgitation (TR). Coronary angiography demonstrated multivessel disease (SYNTAX score 47.5; Fig. 1A, B) with in-stent restenosis of the LM and LAD and chronic total occlusion of the circumflex (Cx). Considering the high risk of mortality (EuroSCORE II 22.1%), the Heart Team opted for PCI supported with percutaneous ventricular assist device. An Impella CP pump was inserted via the right femoral artery (Fig. 1C). Fielder XTR wire supported by the SuperCross 90 microcatheter was used for Cx antegrade penetration. Following multiple predilatations, intravascular lithotripsy was performed in the LM, proximal LAD and proximal Cx (3.0 × 12 mm, 3.5 × 12 mm balloons). LAD segments were further treated using drug--eluting balloons (3.5 × 20 mm, 3.0 × 30 mm). Next, everolimus-eluting stent (3.5 × 15 mm) was implanted into the ostium and proximal Cx using T-stenting and the protrusion technique, followed by kissing balloon inflation in the LAD and Cx (4.0 × 12 mm, 3.5 × 12 mm, respectively) and the proximal optimization technique (5.0 × 8 mm). Intravascular ultrasound confirmed proper expansion and apposition of the stents (Fig. 1D, E). Impella was removed 2 days after the procedure. Echocardiography at 3 months showed LVEF of 23%, moderate MR and mild TR. The use of Impella provided hemodynamic stability, enabl- ing the successful performance of extremely high-risk PCI.
Sky is the limit for Impella-assisted percutaneous coronary intervention: Four technologies, three vessels, two bifurcations and one chronic total occlusion
Abstract
interventionAL CARDIOLOGY
IMAGE IN CARDIOVASCULAR MEDICINE
Cardiology Journal
2023, Vol. 30, No. 6, 1053–1054
DOI: 10.5603/cj.96740
Copyright © 2023 Via Medica
ISSN 1897–5593
eISSN 1898–018X
Sky is the limit for Impella-assisted percutaneous coronary intervention: Four technologies, three vessels, two bifurcations and one chronic total occlusion
Address for correspondence: Dr. Arkadiusz Pietrasik, 1st Chair and Department of Cardiology, Medical University of Warsaw, ul. Banacha 1a, 02–097 Warszawa, Poland, tel: +48 22 599 19 51, fax: +48 22 599 19 57, e-mail: arekpietrasik@icloud.com
Received: 3.08.2023 Accepted: 27.08.2023
This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.